Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    NCT01568229
Show Display Options
Rank Status Study
1 Terminated 20110165: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms (Study 165)
Condition: Schizophrenia
Interventions: Drug: AMG 747;   Drug: Placebo

Indicates status has not been verified in more than two years